A targetable antioxidant defense mechanism to EZH2 inhibitors enhances tumor cell vulnerability to ferroptosis
Abstract Epigenetic changes are present in all human cancers and are responsible for switching on or off genes, thus controlling tumor cell transcriptome. These changes occur through DNA methylation, histone modifiers and readers, chromatin remodelers, and microRNAs. The histone H3 methyl-transferas...
Saved in:
| Main Authors: | Marta C. Nocito, Constanze Hantel, Antonio M. Lerario, Fabrizio Mastrorocco, Luca De Martino, Clara Musicco, Ida D. Perrotta, Mariafrancesca Scalise, Cesare Indiveri, Sergio Giannattasio, Pierre Val, Marilena Lanzino, Vincenzo Pezzi, Ivan Casaburi, Rosa Sirianni |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-04-01
|
| Series: | Cell Death and Disease |
| Online Access: | https://doi.org/10.1038/s41419-025-07607-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
OCTN1 mediates acetylcholine transport in the A549 lung cancer cells: possible pathophysiological implications
by: Lorena Pochini, et al.
Published: (2024-12-01) -
EZH1 deficiency promotes ferroptosis resistance by activating NRF2 in sepsis-associated liver injury
by: Meihua Mei, et al.
Published: (2025-06-01) -
S-nitrosylation of EZH2 alters PRC2 assembly, methyltransferase activity, and EZH2 stability to maintain endothelial homeostasis
by: Ashima Sakhuja, et al.
Published: (2025-04-01) -
Perfusion Bioreactor Technology for Organoid and Tissue Culture: A Mini Review
by: Paola Avena, et al.
Published: (2025-04-01) -
Dual targeting of CXCR4 and EZH2 in endometriosis
by: Sarah Brunty, et al.
Published: (2025-04-01)